Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)

John E. Levine, Bruce R. Blazar, Todd DeFor, James L M Ferrara, Daniel J. Weisdorf

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint Dive into the research topics of 'Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)'. Together they form a unique fingerprint.

Medicine & Life Sciences